chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: received both doses of vaccine/he tested positive for COVID; received both doses of vaccine/he tested positive for COVID; This is a spontaneous report from a contactable nurse. A 32-year-old male patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on left arm on 11Jan2021 13:10 (Batch/Lot Number: EL3246) as 2nd dose, single and dose 1 on 21Dec2020 (Batch/Lot Number: EJ1685) as 1st dose, single at the age of 31 years old for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient had tested negative for COVID-19 on Jul2020. The patient received both doses of vaccine and had symptoms started on 22Apr2021 and he tested positive for COVID on 24Apr2021. The patient would like to know what should he do or how to proceed, if he needs to get a booster or get the vaccine series again. He did take 400 mg of Ibuprofen. Seriousness criteria: The reporter adds that he does not think this is that serious, his symptoms are fine.  Caller clarifies all symptoms reported are not serious.  If it would not have been for loss of taste or smell, he would not have gotten tested but he thought it was weird.  He was going to be traveling soon so he wanted to double check.  The patient was not hospitalized,. The patient had no multiorgan failure, respiratory, cardiovascular, gastrointestinal/Hepatic, vascular, renal, neurological, hematological and dermatological disorders. The outcome of the events was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure and COVID-19 cannot be ruled out.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: received both doses of vaccine/he tested positive for COVID; received both doses of vaccine/he tested positive for COVID; This is a spontaneous report from a contactable nurse. A 32-year-old male patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on left arm on 11Jan2021 13:10 (Batch/Lot Number: EL3246) as 2nd dose, single and dose 1 on 21Dec2020 (Batch/Lot Number: EJ1685) as 1st dose, single at the age of 31 years old for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient had tested negative for COVID-19 on Jul2020. The patient received both doses of vaccine and had symptoms started on 22Apr2021 and he tested positive for COVID on 24Apr2021. The patient would like to know what should he do or how to proceed, if he needs to get a booster or get the vaccine series again. He did take 400 mg of Ibuprofen. Seriousness criteria: The reporter adds that he does not think this is that serious, his symptoms are fine.  Caller clarifies all symptoms reported are not serious.  If it would not have been for loss of taste or smell, he would not have gotten tested but he thought it was weird.  He was going to be traveling soon so he wanted to double check.  The patient was not hospitalized,. The patient had no multiorgan failure, respiratory, cardiovascular, gastrointestinal/Hepatic, vascular, renal, neurological, hematological and dermatological disorders. The outcome of the events was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure and COVID-19 cannot be ruled out.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Cough, Fatigue, Pneumonia
Clinical narrative: pneumonia; Extreme weakness; increased coughing; This is a spontaneous report from a contactable consumer (the patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number ER8736), via an unspecified route of administration on 23Apr2021 at 16:00 (at the age of 38-years-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient has a known allergy to penicillin. Prior to vaccination, the patient had not been diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient reported that she experienced extreme weakness beginning at 9:00 on 24Apr2021 which was still occurring four days later. She experienced increased coughing and was diagnosed by Chest X-ray with pneumonia on 27Apr2021.  The events required an Emergency Room visit. The patient experienced pneumonia on 27Apr2021with outcome of recovering, extreme weakness  on 24Apr2021 at 09:00 with outcome of recovering and increased coughing on 24Apr2021 at 09:00 with outcome of recovering. The patient underwent lab tests and procedures which included x-ray: pneumonia  on 27Apr2021.  Therapeutic measures were taken as a result of pneumonia, extreme weakness and increased coughing and included the administration of a "Z-Pack." Additional information has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cough, Pneumonia, X-ray
Clinical narrative: pneumonia; Extreme weakness; increased coughing; This is a spontaneous report from a contactable consumer (the patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number ER8736), via an unspecified route of administration on 23Apr2021 at 16:00 (at the age of 38-years-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient has a known allergy to penicillin. Prior to vaccination, the patient had not been diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient reported that she experienced extreme weakness beginning at 9:00 on 24Apr2021 which was still occurring four days later. She experienced increased coughing and was diagnosed by Chest X-ray with pneumonia on 27Apr2021.  The events required an Emergency Room visit. The patient experienced pneumonia on 27Apr2021with outcome of recovering, extreme weakness  on 24Apr2021 at 09:00 with outcome of recovering and increased coughing on 24Apr2021 at 09:00 with outcome of recovering. The patient underwent lab tests and procedures which included x-ray: pneumonia  on 27Apr2021.  Therapeutic measures were taken as a result of pneumonia, extreme weakness and increased coughing and included the administration of a "Z-Pack." Additional information has been requested.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Disorientation, Heart rate increased, Impaired driving ability
Clinical narrative: Elevated heart rate; disorientation and a sort of adrenaline like rush; Elevated heart rate; disorientation and a sort of adrenaline like rush; I started to experience trouble driving my car; sort of adrenaline like rush; This is a spontaneous report received from a contactable consumer, the patient. This 47-year-old male patient reported for himself that he received the first dose of BNT162b2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via unspecified route in the left arm on 02Mar2021 at 10:15 as a single dose and the second dose of BNT162b2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via unspecified route in the left arm on 23Mar2021 at 10:15, both doses at the age of 47-years-old, both for COVID-19 immunization. Medical history included high blood pressure, pre-diabetic, and overweight. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine besylate 5mg and ibuprofen (ADVIL). On 02Mar2021 at 11:00, the patient experienced difficult operating a motor vehicle at speeds over about 45 mph. He drove to the vaccination appointment that morning and everything was fine. Driving home from the jab, he started to experience trouble driving his car when crossing a major bridge. The feeling was akin to the anticipatory feeling of being on a climbing roller coaster or drop ride in an amusement park described as elevated heart rate; disorientation and a sort of adrenaline like rush. He was driven to the second jab. The events were reported as serious for Disabling/Incapacitating and resulted in disability or permanent damage. The patient reported that the issue continues now, close to 2 months after it began 45 minutes after receiving the first jab. He stated can drive on local streets but not on a freeway or significant bridge. In the several months prior to the jab, he was driving extensively with no issues. The patient was not treated for difficult operating a motor vehicle/ trouble driving my car, elevated heart rate; disorientation and a sort of adrenaline like rush. The clinical outcome of events difficult operating a motor vehicle/ trouble driving my car, elevated heart rate; disorientation and a sort of adrenaline like rush was not recovered. It was also reported, "Device Date: 28Apr2021" (not further specified). Since the vaccination, the patient has not been tested for COVID-19.   The lot number for the vaccine, BNT162b2 , was not provided and will be requested during follow-up.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Agitation, Disorientation, Heart rate increased, Impaired driving ability
Clinical narrative: Elevated heart rate; disorientation and a sort of adrenaline like rush; Elevated heart rate; disorientation and a sort of adrenaline like rush; I started to experience trouble driving my car; sort of adrenaline like rush; This is a spontaneous report received from a contactable consumer, the patient. This 47-year-old male patient reported for himself that he received the first dose of BNT162b2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via unspecified route in the left arm on 02Mar2021 at 10:15 as a single dose and the second dose of BNT162b2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via unspecified route in the left arm on 23Mar2021 at 10:15, both doses at the age of 47-years-old, both for COVID-19 immunization. Medical history included high blood pressure, pre-diabetic, and overweight. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine besylate 5mg and ibuprofen (ADVIL). On 02Mar2021 at 11:00, the patient experienced difficult operating a motor vehicle at speeds over about 45 mph. He drove to the vaccination appointment that morning and everything was fine. Driving home from the jab, he started to experience trouble driving his car when crossing a major bridge. The feeling was akin to the anticipatory feeling of being on a climbing roller coaster or drop ride in an amusement park described as elevated heart rate; disorientation and a sort of adrenaline like rush. He was driven to the second jab. The events were reported as serious for Disabling/Incapacitating and resulted in disability or permanent damage. The patient reported that the issue continues now, close to 2 months after it began 45 minutes after receiving the first jab. He stated can drive on local streets but not on a freeway or significant bridge. In the several months prior to the jab, he was driving extensively with no issues. The patient was not treated for difficult operating a motor vehicle/ trouble driving my car, elevated heart rate; disorientation and a sort of adrenaline like rush. The clinical outcome of events difficult operating a motor vehicle/ trouble driving my car, elevated heart rate; disorientation and a sort of adrenaline like rush was not recovered. It was also reported, "Device Date: 28Apr2021" (not further specified). Since the vaccination, the patient has not been tested for COVID-19.   The lot number for the vaccine, BNT162b2 , was not provided and will be requested during follow-up.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Immediate post-injection reaction
Clinical narrative: I?ve been having numbness and tingling throughout my body. It jumps around from my arms/fingers, legs:toes, and most recently face. It varies in severity from mild tingles to pins and needles. Some lightheadedness and muscle weakness. I saw the doctor on Monday and he did a physical exam for reflexes and muscle strength etc. he ordered labs for me to rule out anything medically causing the numbness. A day by day symptom list is listed below. Tomorrow will be one week with numbness. I have emailed the doctor again tonight as the blood work results have begun to come back with nothing abnormal, I believe the next step will be to see the neurologist.   Onset - 6th at 1 pm.  Numbness in right arm and lightheaded.  Right eye felt heavy. Friday - 7th - felt some in both arms and legs.  Mild tingling.  Noticed legs felt tingly. Saturday - 8th - during day - Numbness in legs during car ride.  Night at bedtime - very anxious.  Moved to left side based on how she was leaning in bed. Sunday - 9th - all on left side.   Monday - 10th - saw dr.  Isolated to left arm.  Lightheaded in the morning.  Legs were bad at gymnastics after sitting on bleachers. Tuesday- 11th - left side worse, not as isolated.  Left side of face jaw line to mouth and in neck.  Around 4:15 pm. Wednesday - Tiny bit in face (7-?). Legs and arms.  Primarily left arm.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Asthenopia, Blood glucose normal, Differential white blood cell count normal, Dizziness
Clinical narrative: I?ve been having numbness and tingling throughout my body. It jumps around from my arms/fingers, legs:toes, and most recently face. It varies in severity from mild tingles to pins and needles. Some lightheadedness and muscle weakness. I saw the doctor on Monday and he did a physical exam for reflexes and muscle strength etc. he ordered labs for me to rule out anything medically causing the numbness. A day by day symptom list is listed below. Tomorrow will be one week with numbness. I have emailed the doctor again tonight as the blood work results have begun to come back with nothing abnormal, I believe the next step will be to see the neurologist.   Onset - 6th at 1 pm.  Numbness in right arm and lightheaded.  Right eye felt heavy. Friday - 7th - felt some in both arms and legs.  Mild tingling.  Noticed legs felt tingly. Saturday - 8th - during day - Numbness in legs during car ride.  Night at bedtime - very anxious.  Moved to left side based on how she was leaning in bed. Sunday - 9th - all on left side.   Monday - 10th - saw dr.  Isolated to left arm.  Lightheaded in the morning.  Legs were bad at gymnastics after sitting on bleachers. Tuesday- 11th - left side worse, not as isolated.  Left side of face jaw line to mouth and in neck.  Around 4:15 pm. Wednesday - Tiny bit in face (7-?). Legs and arms.  Primarily left arm.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrophoresis protein, Full blood count normal, Glycosylated haemoglobin normal, Hemiparesis, Hypoaesthesia
Clinical narrative: I?ve been having numbness and tingling throughout my body. It jumps around from my arms/fingers, legs:toes, and most recently face. It varies in severity from mild tingles to pins and needles. Some lightheadedness and muscle weakness. I saw the doctor on Monday and he did a physical exam for reflexes and muscle strength etc. he ordered labs for me to rule out anything medically causing the numbness. A day by day symptom list is listed below. Tomorrow will be one week with numbness. I have emailed the doctor again tonight as the blood work results have begun to come back with nothing abnormal, I believe the next step will be to see the neurologist.   Onset - 6th at 1 pm.  Numbness in right arm and lightheaded.  Right eye felt heavy. Friday - 7th - felt some in both arms and legs.  Mild tingling.  Noticed legs felt tingly. Saturday - 8th - during day - Numbness in legs during car ride.  Night at bedtime - very anxious.  Moved to left side based on how she was leaning in bed. Sunday - 9th - all on left side.   Monday - 10th - saw dr.  Isolated to left arm.  Lightheaded in the morning.  Legs were bad at gymnastics after sitting on bleachers. Tuesday- 11th - left side worse, not as isolated.  Left side of face jaw line to mouth and in neck.  Around 4:15 pm. Wednesday - Tiny bit in face (7-?). Legs and arms.  Primarily left arm.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test normal, Muscular weakness, Paraesthesia, Red blood cell sedimentation rate normal, Thyroid function test normal
Clinical narrative: I?ve been having numbness and tingling throughout my body. It jumps around from my arms/fingers, legs:toes, and most recently face. It varies in severity from mild tingles to pins and needles. Some lightheadedness and muscle weakness. I saw the doctor on Monday and he did a physical exam for reflexes and muscle strength etc. he ordered labs for me to rule out anything medically causing the numbness. A day by day symptom list is listed below. Tomorrow will be one week with numbness. I have emailed the doctor again tonight as the blood work results have begun to come back with nothing abnormal, I believe the next step will be to see the neurologist.   Onset - 6th at 1 pm.  Numbness in right arm and lightheaded.  Right eye felt heavy. Friday - 7th - felt some in both arms and legs.  Mild tingling.  Noticed legs felt tingly. Saturday - 8th - during day - Numbness in legs during car ride.  Night at bedtime - very anxious.  Moved to left side based on how she was leaning in bed. Sunday - 9th - all on left side.   Monday - 10th - saw dr.  Isolated to left arm.  Lightheaded in the morning.  Legs were bad at gymnastics after sitting on bleachers. Tuesday- 11th - left side worse, not as isolated.  Left side of face jaw line to mouth and in neck.  Around 4:15 pm. Wednesday - Tiny bit in face (7-?). Legs and arms.  Primarily left arm.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vitamin B12 normal
Clinical narrative: I?ve been having numbness and tingling throughout my body. It jumps around from my arms/fingers, legs:toes, and most recently face. It varies in severity from mild tingles to pins and needles. Some lightheadedness and muscle weakness. I saw the doctor on Monday and he did a physical exam for reflexes and muscle strength etc. he ordered labs for me to rule out anything medically causing the numbness. A day by day symptom list is listed below. Tomorrow will be one week with numbness. I have emailed the doctor again tonight as the blood work results have begun to come back with nothing abnormal, I believe the next step will be to see the neurologist.   Onset - 6th at 1 pm.  Numbness in right arm and lightheaded.  Right eye felt heavy. Friday - 7th - felt some in both arms and legs.  Mild tingling.  Noticed legs felt tingly. Saturday - 8th - during day - Numbness in legs during car ride.  Night at bedtime - very anxious.  Moved to left side based on how she was leaning in bed. Sunday - 9th - all on left side.   Monday - 10th - saw dr.  Isolated to left arm.  Lightheaded in the morning.  Legs were bad at gymnastics after sitting on bleachers. Tuesday- 11th - left side worse, not as isolated.  Left side of face jaw line to mouth and in neck.  Around 4:15 pm. Wednesday - Tiny bit in face (7-?). Legs and arms.  Primarily left arm.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pruritus, Rash
Clinical narrative: Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; This is a spontaneous report from a contactable consumer from a non-measurable supplier. A 47-year-old female patient received first dose of BNT162B2 (BNT162B2 solution for injection, Lot Number: EW0175) via intramuscular route  in arm left on 29Apr2021 at 13:45  for covid-19 immunisation. Medical history included allergy. Concomitant medication was not reported. On 30Apr2021 at 19:00, the patient had experienced hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area. Tthe patient was hospitalized and the patient received treatment with Steriod pak and pepcid. The outcome of events was recovering.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; Red hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area; This is a spontaneous report from a contactable consumer from a non-measurable supplier. A 47-year-old female patient received first dose of BNT162B2 (BNT162B2 solution for injection, Lot Number: EW0175) via intramuscular route  in arm left on 29Apr2021 at 13:45  for covid-19 immunisation. Medical history included allergy. Concomitant medication was not reported. On 30Apr2021 at 19:00, the patient had experienced hot itchy bumpy rash on arms, breast, chest, stomach, back and groin area. Tthe patient was hospitalized and the patient received treatment with Steriod pak and pepcid. The outcome of events was recovering.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arteriogram carotid normal, Cerebral artery occlusion, Cerebrovascular accident, Coagulation test normal, Computerised tomogram normal
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count normal, Perfusion brain scan abnormal
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Antiphospholipid antibodies negative, Cerebral artery thrombosis, Cerebrovascular accident, Computerised tomogram coronary artery normal
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram neck, Dysarthria, Ejection fraction normal, Electrocardiogram, Facial paralysis
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hemiparesis, Platelet count normal, Platelet factor 4, Protein C decreased, Protein S decreased
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast abnormal, Thrombectomy, Thrombin time prolonged
Clinical narrative: patient presented with acute stroke on 5/2/2021. Symptoms included facial droop, left sided weakness and slurred speech (SS = 8). CTA revealed right MCA thrombus. Patient received alteplase and underwent thrombectomy procedure to right M2.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Anticoagulant therapy, Chest pain, Computerised tomogram, Dyspnoea
Clinical narrative: pulmonary embolus
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pain in extremity, Pulmonary thrombosis, Ultrasound scan
Clinical narrative: pulmonary embolus
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Pulmonary embolism
Clinical narrative: pulmonary embolus
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest X-ray, Chest X-ray normal, Chest pain, Chills
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram, Electrocardiogram ST segment elevation, Full blood count abnormal, Magnetic resonance imaging heart
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test abnormal, Myalgia, Myocarditis, Pyrexia, Troponin increased
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest pain, Dyspnoea, Echocardiogram, Electrocardiogram PR interval
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ST segment abnormal, Left ventricular dysfunction, Magnetic resonance imaging heart, Myocardial oedema, Myocarditis
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: 16 yo male who presented with chest pain and dyspnea 2 days after receiving 2nd dose of COVID pfizer vaccine, and found to have elevated troponin and CRP and EKG with ST changes and PR interval depressions which is most consistent with myopericarditis. Troponin trend: 1.9 -- > 11.1 -- > 10.5 -- > 7.1, down-trending on discharge. Chest pain managed with scheduled ibuprofen, resolved on discharge. Repeat EKGs consistent with admission EKG. TTE performed 5/3, showing EF 67.8% without LV dysfx, valvular insufficiency, RV dysfx.  Cardiac MRI - reported below
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient died 20 hours after receiving Pfizer vaccine; Very ill/very sick; diarrhea; Severe chills; fever; Body aches; This is a spontaneous report from a contactable consumer. A 68-year-old non-pregnant female patient received the second of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Apr2021 (Batch/Lot number was not reported) (at age of 68-year-old) as single dose for covid-19 immunisation. Medical history included obesity/Overweight. There was no known allergies. There were no concomitant medications. There was no other vaccine in four weeks. The patient received the first dose of BNT162B2 on unknown date for Covid-19 immunization. It was reported the patient didn't  have any health condition other than she was overweight. She received her second Pfizer dose and became very ill. She received her vaccine in the morning and by the evening, she had diarrhea and then she started getting body aches and she had the worst chills of her life followed by the fever. Also, she was up all night taking Tylenol and in the morning, she contacted my brother at 07:00 AM to tell him that she was very sick and she was taking Tylenol all night and she died an hour later. The date for her death was 1May2021, she received the vaccine on 30Apr2021 and she died on 1May2021 at 08:00 AM in the morning. As for reason of death, reporter stated, "There was no other conditions other than her becoming very sick from the vaccine."  Treatment was received for the events included Tylenol. There was no COVID prior vaccination or no COVID  tested post vaccination.  The outcome of event 'Patient died 20 hours after receiving Pfizer vaccine' was fatal and of other events was unknown.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: Patient died 20 hours after receiving Pfizer vaccine
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Death, Diarrhoea, Illness, Pain
Clinical narrative: Patient died 20 hours after receiving Pfizer vaccine; Very ill/very sick; diarrhea; Severe chills; fever; Body aches; This is a spontaneous report from a contactable consumer. A 68-year-old non-pregnant female patient received the second of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Apr2021 (Batch/Lot number was not reported) (at age of 68-year-old) as single dose for covid-19 immunisation. Medical history included obesity/Overweight. There was no known allergies. There were no concomitant medications. There was no other vaccine in four weeks. The patient received the first dose of BNT162B2 on unknown date for Covid-19 immunization. It was reported the patient didn't  have any health condition other than she was overweight. She received her second Pfizer dose and became very ill. She received her vaccine in the morning and by the evening, she had diarrhea and then she started getting body aches and she had the worst chills of her life followed by the fever. Also, she was up all night taking Tylenol and in the morning, she contacted my brother at 07:00 AM to tell him that she was very sick and she was taking Tylenol all night and she died an hour later. The date for her death was 1May2021, she received the vaccine on 30Apr2021 and she died on 1May2021 at 08:00 AM in the morning. As for reason of death, reporter stated, "There was no other conditions other than her becoming very sick from the vaccine."  Treatment was received for the events included Tylenol. There was no COVID prior vaccination or no COVID  tested post vaccination.  The outcome of event 'Patient died 20 hours after receiving Pfizer vaccine' was fatal and of other events was unknown.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: Patient died 20 hours after receiving Pfizer vaccine
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Patient died 20 hours after receiving Pfizer vaccine; Very ill/very sick; diarrhea; Severe chills; fever; Body aches; This is a spontaneous report from a contactable consumer. A 68-year-old non-pregnant female patient received the second of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Apr2021 (Batch/Lot number was not reported) (at age of 68-year-old) as single dose for covid-19 immunisation. Medical history included obesity/Overweight. There was no known allergies. There were no concomitant medications. There was no other vaccine in four weeks. The patient received the first dose of BNT162B2 on unknown date for Covid-19 immunization. It was reported the patient didn't  have any health condition other than she was overweight. She received her second Pfizer dose and became very ill. She received her vaccine in the morning and by the evening, she had diarrhea and then she started getting body aches and she had the worst chills of her life followed by the fever. Also, she was up all night taking Tylenol and in the morning, she contacted my brother at 07:00 AM to tell him that she was very sick and she was taking Tylenol all night and she died an hour later. The date for her death was 1May2021, she received the vaccine on 30Apr2021 and she died on 1May2021 at 08:00 AM in the morning. As for reason of death, reporter stated, "There was no other conditions other than her becoming very sick from the vaccine."  Treatment was received for the events included Tylenol. There was no COVID prior vaccination or no COVID  tested post vaccination.  The outcome of event 'Patient died 20 hours after receiving Pfizer vaccine' was fatal and of other events was unknown.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: Patient died 20 hours after receiving Pfizer vaccine
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Blood creatine phosphokinase normal, Blood lactic acid, Blood test, C-reactive protein increased
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Electrocardiogram normal, Laboratory test, Renal artery thrombosis, Ultrasound scan normal
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Urine analysis
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Blood test, Cerebrovascular accident, Computerised tomogram, Decreased appetite
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Discomfort, Imaging procedure, Renal disorder, Thrombosis, Urine analysis
Clinical narrative: part of my left kidney was no longer receiving blood; blood clot; placed on stroke protocols.; I developed severe abdominal pain in my left side during the evening; lack of appetite; bouts of severe discomfort; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EW0167) via an unspecified route of administration, administered in Arm Left on 28Apr2021 12:15 (40-years-old) as 2nd dose, single for COVID-19 immunization. The patient medical history was not reported. Vaccination Facility Type was clinic. Concomitant medications included ibuprofen (ADVIL); desloratadine (CLARINEX). The patient previously took first dose of BNT162B2 (lot number=EN6208) on 07Apr2021 01:15 PM (40-years-old) on Left arm for COVID-19 immunization. It was reported that the patient developed severe abdominal pain in my left side during the evening of Wednesday, 28Apr2021 19:00. The pain appeared sporadically throughout the evening and continued through Friday, April 30. During this time, he experienced a lack of appetite and bouts of severe discomfort. Tried treating with GasX and Tylenol. Duration of Hospitalization reported as 3 days. On Saturday, 01May2021, starting around 10:30 a.m., the pain in his left-side abdominal area intensified and did not diminish. After 6 hours, he visited the ER at hospital. After being admitted to the ER, a series of blood, urine and imaging tests were performed on me. The doctor on duty reported that a CT scan showed that part of my left kidney was no longer receiving blood (disability). He was placed on Heparin and admitted to the hospital. He was diagnosed with a blood clot and placed on stroke protocols. The adverse event result in  Emergency room/department or urgent care. Treatment received for the adverse events was Heparin, fluids, blood work, urine analysis. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events abdominal pain, lack of appetite, and bouts of severe discomfort was recovering; while other events was unknown.  Events reported as serious due to hospitalization and life threatening.